Broadfin Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$21.1M Buy
1,033,500
+784,500
+315% +$15.6M 2.82% 9
2019
Q3
$4.86M Buy
+249,000
New +$5.42M 0.9% 27
2013
Q4
Sell
-450,000
Closed -$15.1M 61
2013
Q3
$15.1M Sell
450,000
-150,000
-25% -$4.88M 2.69% 14
2013
Q2
$17.2M Buy
+600,000
New +$17.5M 3.37% 11

Other funds holding ALKS

Broadfin Capital's ALKS Position: Q4 2019 in Review

Broadfin Capital increased its Alkermes (ALKS) stake by 315% in Q4 2019, buying an estimated $15.6M and bringing the position to 1,033,500 shares worth $21.1M. The position accounts for 2.82% of the portfolio, ranked #9.

Broadfin Capital first reported a position in ALKS in Q2 2013 and has held it in 4 quarters since. 216 funds tracked by Wall St. Rank hold ALKS as of Q4 2019.

  • Broadfin Capital held 1,033,500 shares of Alkermes worth $21.1M as of Q4 2019.
  • Broadfin Capital bought 784,500 Alkermes shares in Q4 2019, an estimated $15.6M.
  • Alkermes made up 2.82% of Broadfin Capital's portfolio in Q4 2019, its #9 holding.
  • Broadfin Capital first reported a position in Alkermes in Q2 2013 and has held it in 4 quarters since.
  • 216 funds tracked by Wall St. Rank held Alkermes as of Q4 2019.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.